REDUCED NA+-K+-ATPASE ACTIVITY AND PLASMA LYSOPHOSPHATIDYLCHOLINE CONCENTRATIONS IN DIABETIC-PATIENTS
REDUCED NA+-K+-ATPASE ACTIVITY AND PLASMA LYSOPHOSPHATIDYLCHOLINE CONCENTRATIONS IN DIABETIC-PATIENTS
复制标题
DOI:
10.2337/diabetes.43.7.915
复制
发表时间:
1994-07-01
期刊:
影响因子:
7.7
通讯作者:
MAZZANTI, L
中科院分区:
文献类型:
--
作者:
RABINI, RA;GALASSI, R;MAZZANTI, L
A fraction from normal human plasma inhibiting Na+-K+ ATPase has been recently identified as lysophosphatidylcholine (LPC). The aim of this study was to investigate the existence of a relationship between the activity of the cellular membrane Na+-K+-ATPase and plasma LPC in human diabetes. We studied 10 patients with insulin-dependent diabetes mellitus (IDDM), 14 patients with non-insulin-dependent diabetes mellitus (NIDDM), and 10 sex- and age-matched control subjects. Plasma LPC concentrations were increased in both IDDM and NIDDM patients compared with control subjects. Na+-K+-ATPase activity was reduced in both groups of patients in erythrocyte and platelet membranes. There was a significant correlation between the concentrations of plasma LPC and N2(+)-K+-ATPase activity in both erythrocyte and platelet membranes (P < 0.01). To investigate the effect of LPC on the enzyme, Na+-K+-ATPase activity was determined in erythrocyte membranes obtained from six healthy subjects after in vitro incubation with increasing concentrations of LPC (1-10 mu M). Enzymatic activity was significantly reduced by in vitro LPC at a concentration of 2.5 mu M, with a further decrease at 5 mu M. These data suggest that the decrease in Na+-K+-ATPase activity in diabetes might be due to increased LPC concentrations.